Difficulty: Medium
Average Score: 70%
Testbank
A patient with cardiovascular disease is being treated with amlodipine (Norvasc), a calcium channel blocking agent. The therapeutic effects of calcium channel blockers include which of the following?
Correct answer
A
Rationale
A: Reducing the hearts workload by decreasing heart rate and myocardial contraction.
Calcium channel blockers like amlodipine primarily work by inhibiting calcium influx into cardiac and vascular smooth muscle cells, leading to vasodilation and a decrease in heart rate and myocardial contractility. This reduction in workload is beneficial for patients with cardiovascular disease, as it helps to lower blood pressure and decrease the heart's oxygen demand.
B: Preventing platelet aggregation and subsequent thrombosis.
Calcium channel blockers do not have a primary role in inhibiting platelet aggregation; this function is more characteristic of antiplatelet medications such as aspirin or clopidogrel, which target different pathways.
C: Reducing myocardial oxygen consumption by blocking adrenergic stimulation to the heart.
While calcium channel blockers decrease myocardial oxygen demand, they do not primarily function by blocking adrenergic stimulation; rather, they directly affect calcium channels, which is a different mechanism than adrenergic blockade.
D: Increasing the efficiency of myocardial oxygen consumption, thus decreasing ischemia and relieving pain.
Calcium channel blockers do not increase the efficiency of myocardial oxygen consumption; instead, they reduce the workload of the heart, which can help alleviate ischemia but does not enhance oxygen utilization efficiency.
Calcium channel blockers like amlodipine primarily work by inhibiting calcium influx into cardiac and vascular smooth muscle cells, leading to vasodilation and a decrease in heart rate and myocardial contractility. This reduction in workload is beneficial for patients with cardiovascular disease, as it helps to lower blood pressure and decrease the heart's oxygen demand.
B: Preventing platelet aggregation and subsequent thrombosis.
Calcium channel blockers do not have a primary role in inhibiting platelet aggregation; this function is more characteristic of antiplatelet medications such as aspirin or clopidogrel, which target different pathways.
C: Reducing myocardial oxygen consumption by blocking adrenergic stimulation to the heart.
While calcium channel blockers decrease myocardial oxygen demand, they do not primarily function by blocking adrenergic stimulation; rather, they directly affect calcium channels, which is a different mechanism than adrenergic blockade.
D: Increasing the efficiency of myocardial oxygen consumption, thus decreasing ischemia and relieving pain.
Calcium channel blockers do not increase the efficiency of myocardial oxygen consumption; instead, they reduce the workload of the heart, which can help alleviate ischemia but does not enhance oxygen utilization efficiency.